Chromosomal microarray analysis for pregnancies with abnormal maternal serum screening who undergo invasive prenatal testing

Recently, chromosomal microarray analysis (CMA) has been implemented as a first‐tier test in pregnancies with ultrasound anomalies. However, its application for pregnancies with abnormal maternal serum screening (AMSS) only is not widespread. This study evaluated the value of CMA compared to traditi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaoqing, Li, Ying, Lin, Na, Xie, Xiaorui, Su, Linjuan, Cai, Meiying, Lin, Yuan, Wang, Linshuo, Wang, Meiying, Xu, Liangpu, Huang, Hailong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256361/
https://www.ncbi.nlm.nih.gov/pubmed/34042265
http://dx.doi.org/10.1111/jcmm.16589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256361/
https://www.ncbi.nlm.nih.gov/pubmed/34042265
http://dx.doi.org/10.1111/jcmm.16589

Ejemplares similares